Model of Complications of NIDDM: I. Model construction and assumptions

Author:

Eastman Richard C1,Javitt Jonathan C2,Herman William H3,Dasbach Erik J4,Zbrozek Arthur S5,Dong Fred6,Manninen Diane6,Garfield Sanford A1,Copley-Merriman Catherine7,Maier William7,Eastman Jeffery F8,Kotsanos James9,Cowie Catherine C1,Harris Maureen1

Affiliation:

1. Division of Diabetes, Endocrinology, and Metabolic Diseases Indianapolis, Indiana

2. National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, Maryland Department of Ophthalmology Indianapolis, Indiana

3. Worthen Center for Eye Care Research, Georgetown University, School of Medicine Washington, D.C. Division of Endocrinology and Metabolism Indianapolis, Indiana

4. Parke-Davis Inc., Ann Arbor, Michigan; Merck Inc. Indianapolis, Indiana

5. Bluebell, Pennsylvania Bayer Inc. Indianapolis, Indiana

6. West Haven, Connecticut Battelle Inc. Indianapolis, Indiana

7. Department of Internal Medicine, University of Michigan, Epidemiology and Outcomes Research Indianapolis, Indiana

8. Seattle, Washington Windward Solutions Indianapolis, Indiana

9. Redwood City, California Eli Lilly Inc.Indianapolis, Indiana

Abstract

OBJECTIVE To develop a model of NIDDM for analyzing prevention strategies for NIDDM. RESEARCH DESIGN AND METHODS A Markov type model with Monte Carlo techniques was used. Age, sex, and ethnicity of cohort was based on U.S. data. Incidence rates of complications were also based on community and population studies. RESULTS Nonproliferative retinopathy, proliferative retinopathy, and macular edema are predicted in 79, 19, and 52%, respectively, of people with NIDDM; 19% are predicted to develop legal blindness. Microalbuminuria, gross proteinuria, and end-stage renal disease related to diabetes are predicted in 53, 40, and 17%, respectively. Symptomatic sensorimotor neuropathy and lower-extremity amputation are predicted in 31 and 17%, respectively. Cardiovascular disease is predicted in 39%. Higher rates of complications (1.1−3.0×) are predicted in minority populations. Predicted average life expectancy is 17 years after diagnosis. CONCLUSIONS A probabilistic model of NIDDM predicts the vascular complications of NIDDM in a cohort representative of the incident cases of diabetes in the U.S. before age 75 years. Predictions of complications and mortality are consistent with the known epidemiology of NIDDM. The model is suitable for evaluating the effect of preventive interventions on the natural history of NIDDM.

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3